Positions and Honors
- 1999-2000 Resident, Pediatric Optometry, Indiana University School of Optometry
- 2000-2002 Visiting Assistant Clinical Professor, Indiana University School of Optometry
- 2000-2004 Staff Optometrist, Indiana University School of Medicine Pediatric Ophthalmology
- 2002-2007 Assistant Clinical Professor, Indiana University School of Optometry
- 2007-2012 Associate Clinical Professor, Indiana University School of Optometry
- 2012- Clinical Professor, Indiana University School of Optometry
- 2002- Member Pediatric Eye Disease Investigator Group
- 2003-2008 Member Amblyopia Treatment Studies Planning Committee
- 2004-2007 Member Amblyopia Treatment Studies Steering Committee
- 2004-2008 Co-protocol Chair for Amblyopia Treatment Study 6, PEDIG
- 2005-2010 Member Correction of Myopia Evaluation Trial-2 Steering Committee,
- 2005-2009 Protocol Chair Amblyopia Treatment Study Incorporating VISION THERAPY ,
- January 2003 Pediatric Eye Disease Investigator Group Award for Outstanding New Clinical
- Site 2002 in Amblyopia Treatment Studies
- January 2004 Pediatric Eye Disease Investigator Group 2003 Clinical Site Performance
- March 2008 Awarded an Association for CLINICAL RESEARCH Training Travel Award-
- Burroughs Wellcome Fund
- November 2009 KA Coffman Friend of School Nursing: Presented by the Indiana State School
- Nurses Association
- Pediatric Eye Disease Investigator Group (Lyon DW, PI of Indiana University School of Optometry, member of writing cttee)
- A Randomized Pilot Study of Near Activities Versus Non-Near Activities During Patching Therapy for Amblyopia.
- Journal of American Association for Pediatric Ophthalmology and Strabismus. 2005, 9:2; 129-136
- Lyon, DW, Goss DA, Horner D, et al. Normative Data for Modified Thorington Phorias and Prism Bar Vergences From the Benton-IU Study. Optometry, October 2005; 76:593-9
- Holmes, JM, Lyon DW, Samara, OD (For the Pediatric Eye Disease Investigator Group) Near Versus Distance Activities While Patching for Amblyopia in Children Aged 3 to Less Than 7 Years. Ophthalmol 2008; 115(11) 2071-2078
- Correction of Myopia Evaluation Trial 2 Study Group. (Lyon, DW member of steering cttee, member of writing cttee)
- Accommodative lag by autorefraction and two dynamic retinoscopy methods. Optom Vis Sci 2009;86(3):233-43
- Correction of Myopia Evaluation Trial 2 Study Group. (Lyon, DW member of steering cttee, member of writing cttee)
- Progressive-Addition Lenses versus Single-Vision Lenses for Slowing Progression of Myopia in Children with High Accommodative Lag and Near Esophoria. INVEST Ophthalmol Vis Sci 2011;52(5):2749-57
- Lyon DW, Hopkins K, Chu RH, Tampkins SM, Cotter SA, Melia M, Holmes JM, Repka MX, Wheeler DT, Sala NA, Dumas JD, Silbert DI, on behalf of Pediatric Eye Disease Investigator Group.
- Feasibility of a clinical trial of VISION THERAPY for treatment of amblyopia. Optom Vis Sci 2013;90(5): 475-81
- 2009-Present Clinical Trials in Strabismus and Pediatric Ophthalmology: A Randomized Clinical Trial of Observation versus Occlusion Therapy for Intermittent Exotropia IXT- Principal Investigator: Roy Beck, Local Principal Investigator, Don W. Lyon, OD
- Agency: National Eye Institute NIH-NEI 5-U10 EY 11751 (Beck)
- 2. 2009-Present Clinical Trials in Strabismus and Pediatric Ophthalmology: Amblyopia
- Treatment-15Augmenting Patching Treatment for Amblyopia Therapy
- Principal Investigator: Roy Beck
- Local Principal Investigator, Don W. Lyon, OD
- Agency: National Eye Institute NIH-NEI 5-U10 EY 11751 (Beck)
- 2007-2009 Clinical Trials in Strabismus and Pediatric Ophthalmology: A Randomized Trial
- Comparing Patching with Active VISION THERAPY to Patching with Control Vision
- Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old. Principal Investigator: Roy Beck. Local Principal Investigator, Chair Planning Committee, Chair Steering Committee, Protocol Chair: Don W. Lyon, O.D. Agency: National Eye Institute NIH-NEI 5-U10 EY 11751 (Beck)
- 2005-2009 Clinical Trials in Strabismus and Pediatric Ophthalmology: Correction of Myopia. Evaluation Trial. Principal Investigator: Roy Beck. Local Principal Investigator, Member Steering Committee: Don W. Lyon, O.D.
- Agency: National Eye Institute Type: NIH-NEI 5-U10 EY 11751 (Beck) Dr. JA de Lange
No comments:
Post a Comment